Dr. Sana Alomari Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Closter Dock Rd, Closter, NJ 07624 Phone: 201-497-6100 |
Hae Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Closter Dock Rd, Closter, NJ 07624 Phone: 201-230-5449 |
Mr. Vincent Joseph Proietti, BS, BPH, JD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Demarest Ave, Closter, NJ 07624 Phone: 201-784-7190 Fax: 201-784-7197 |
Carl Joseph Garcia Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Closter Dock Rd, Closter, NJ 07624 Phone: 201-767-6890 |
Dr. Annette Kherlopian, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Demarest Ave, Closter, NJ 07624 Phone: 201-784-7190 |
Mark Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Forest St, Closter, NJ 07624 Phone: 201-906-8258 |
Mina Khalil, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 29 Ver Valen St, Closter, NJ 07624 Phone: 201-367-1405 |
Jean-marie Trampel, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 68 Chestnut Ave, Closter, NJ 07624 Phone: 201-768-2303 |
Diane Cohen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Closter Dock Rd, Closter, NJ 07624 Phone: 201-767-6890 |
Dr. Lauren Kissel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Demarest Ave, Closter, NJ 07624 Phone: 201-784-7190 |
News Archive
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
A recent Northeastern University study has shown, for the first time, the effect of individual genes on the fitness of a marine species at the ecosystem level.
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Forest Laboratories, Inc. and Pierre Fabre Medicament today announced preliminary top-line results from a Phase III study of levomilnacipran for the treatment of adults with major depressive disorder (MDD).
› Verified 8 days ago